Effects of mesenchymal stem cell-derived extracellular vesicles and exosomes on inflammatory, regenerative, and renal–hepatic laboratory biomarkers in rat injury models: a systematic review
Indonesia Journal of Biomedical Science · 20.09.2026 · 20 (2)
DOI: 10.15562/ijbs.v20i2.695 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Indonesia Journal of Biomedical Science, online erschienen am 20.09.2026. Verfasst von Si Ngurah Oka Putrawan und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Mesenchymal stem/stromal cell (MSC)-derived extracellular vesicles (EVs) and exosomes are being developed as cell-free regenerative and cytoprotective agents. In preclinical rat models, the laboratory read-outs used to judge their efficacy, and their systemic tolerability are reported unevenly and have not been consolidated for a strictly EV-defined evidence base. This study aims to systematically evaluate whether defined, characterized MSC-derived EV/exosome preparations improve inflammatory markers, regenerative/anti-fibrotic biomarkers, and renal–hepatic laboratory profiles in rat injury models, and to distinguish target-organ efficacy from systemic safety.
Methods
The review followed PRISMA 2020. Eligible studies were in vivo rat injury models treated with a defined, EV-characterised MSC-derived exosome/EV preparation against a comparator and reporting ≥1 relevant biomarker. Conditioned-medium/secretome preparations without EV isolation and characterization, and products delivered only in combination with whole cells or as biomaterial composites, were excluded. Risk of bias was appraised with SYRCLE and reporting completeness against ARRIVE 2.0.
Results
Ten in vivo rat studies met the EV-restricted criteria, spanning acute kidney injury (sepsis-associated and cisplatin), diabetic nephropathy, hepatic/steatotic-graft ischemia–reperfusion, focal cerebral ischemia, spinal cord injury and intestinal ischemia–reperfusion. MSC-derived exosomes were consistently associated with reduced target-organ injury biomarkers: serum creatinine and blood urea nitrogen decreased in all four renal-injury models, and serum aspartate aminotransferase (with alanine aminotransferase and bilirubin) decreased in all three hepatic models. Pro-inflammatory signaling (TNF-α, IL-6, IL-1β, NF-κB) was reduced in most models, with one discordant exception in which serum IL-6, IL-1β and NF-κB rose after stress-induced exosomes despite tissue-level improvement. Anti-fibrotic effects (down-regulated TGF-β1 and collagen) were observed in diabetic nephropathy and hepatic transplantation.
Conclusion
In rat injury models, characterized MSC-derived EV/exosome preparations were consistently associated with improved target-organ injury biomarkers and a predominantly anti-inflammatory profile, but the evidence is preclinical, at largely unclear-to-high risk of bias, and provides essentially no systemic safety-laboratory or hematological data.
Zitieren
APA
Putrawan, S. N. O., Mahayani, I. A. W., Herawati, S., Prabawa, I. P. Y., & Suartini, I. G. A. A. (2026). Effects of mesenchymal stem cell-derived extracellular vesicles and exosomes on inflammatory, regenerative, and renal–hepatic laboratory biomarkers in rat injury models: a systematic review. Indonesia Journal of Biomedical Science, 20(2). https://doi.org/10.15562/ijbs.v20i2.695
Vancouver
Putrawan SNO, Mahayani IAW, Herawati S, Prabawa IPY, Suartini IGAA. Effects of mesenchymal stem cell-derived extracellular vesicles and exosomes on inflammatory, regenerative, and renal–hepatic laboratory biomarkers in rat injury models: a systematic review. Indonesia Journal of Biomedical Science. 2026;20(2). doi:10.15562/ijbs.v20i2.695
BibTeX
@article{Putrawan2026,
author = {Putrawan, Si Ngurah Oka and Mahayani, Ida Ayu Wayan and Herawati, Sianny and Prabawa, I Putu Yuda and Suartini, I Gusti Ayu Agung},
title = {Effects of mesenchymal stem cell-derived extracellular vesicles and exosomes on inflammatory, regenerative, and renal–hepatic laboratory biomarkers in rat injury models: a systematic review},
journal = {Indonesia Journal of Biomedical Science},
year = {2026},
volume = {20},
number = {2},
doi = {10.15562/ijbs.v20i2.695}
}
EUVIMED